Rep. Diana DeGette (D-CO) told reporters and stakeholders Tuesday (April 14) that she has been working closely with FDA on alternative clinical trials language for inclusion in the final version of the Energy and Commerce Committee's Cures bill, which she expects to be unveiled soon. FDA, along with former agency Commissioner Margaret Hamburg, have been “with us every step of the way,” she said. DeGette added that the reforms included in the final bill will need to be adequately funded...